These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1682487)

  • 1. Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist.
    MacDonald E; Scheinin M; Scheinin H; Virtanen R
    J Pharmacol Exp Ther; 1991 Nov; 259(2):848-54. PubMed ID: 1682487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute administration of medetomidine on the behaviour, temperature and turnover rates of brain biogenic amines in rodents and reversal of these effects by atipamezole.
    MacDonald E; Haapalinna A; Virtanen R; Lammintausta R
    Acta Vet Scand Suppl; 1989; 85():77-81. PubMed ID: 2571282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profiles of medetomidine and its antagonist, atipamezole.
    Virtanen R
    Acta Vet Scand Suppl; 1989; 85():29-37. PubMed ID: 2571275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative.
    MacDonald E; Scheinin H; Scheinin M
    Eur J Pharmacol; 1988 Dec; 158(1-2):119-27. PubMed ID: 2906007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 2-adrenoceptor-mediated inhibition of gastric acid secretion by medetomidine is efficiently antagonized by atipamezole in rats.
    Savola M; Savola JM; Puurunen J
    Arch Int Pharmacodyn Ther; 1989; 301():267-76. PubMed ID: 2576195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist.
    Scheinin H; MacDonald E; Scheinin M
    Eur J Pharmacol; 1988 Jun; 151(1):35-42. PubMed ID: 2901363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane.
    Potter DE; Ogidigben MJ
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2799-805. PubMed ID: 1680113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
    Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular actions of medetomidine and their reversal by atipamezole.
    Savola JM
    Acta Vet Scand Suppl; 1989; 85():39-47. PubMed ID: 2571276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protean agonism at alpha2A-adrenoceptors.
    Jansson CC; Kukkonen JP; Näsman J; Huifang G; Wurster S; Virtanen R; Savola JM; Cockcroft V; Akerman KE
    Mol Pharmacol; 1998 May; 53(5):963-8. PubMed ID: 9584224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of medetomidine, an alpha 2-adrenoceptor agonist, in various pain tests.
    Pertovaara A; Kauppila T; Tukeva T
    Eur J Pharmacol; 1990 Apr; 179(3):323-8. PubMed ID: 1973106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
    Doze V; Chen BX; Li Z; Maze M
    Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation.
    Pertovaara A; Bravo R; Herdegen T
    Neuroscience; 1993 May; 54(1):117-26. PubMed ID: 8100045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-adrenergic receptor agonist effects on supraventricular and ventricular automaticity in dogs with complete atrioventricular block.
    Day TK; Muir WW
    Am J Vet Res; 1993 Jan; 54(1):136-41. PubMed ID: 8093993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
    Honoré P; Chapman V; Buritova J; Besson JM
    J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
    Riekkinen P; Lammintausta R; Ekonsalo T; Sirviö J
    Eur J Pharmacol; 1993 Jul; 238(2-3):263-72. PubMed ID: 8104809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
    Chopin P; Colpaert FC; Marien M
    J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of isoflurane anesthetic requirement by medetomidine and its restoration by atipamezole in dogs.
    Ewing KK; Mohammed HO; Scarlett JM; Short CE
    Am J Vet Res; 1993 Feb; 54(2):294-9. PubMed ID: 8094277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of alpha 2-adrenoceptor antagonists with medetomidine and with ethanol in a holeboard test.
    Durcan MJ; Lister RG; Linnoila M
    Neuropharmacology; 1989 Mar; 28(3):275-81. PubMed ID: 2566945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.